Item request has been placed!
×
Item request cannot be made.
×
Processing Request
The Development of Ofatumumab, a Fully Human Anti-CD20 Monoclonal Antibody for Practical Use in Relapsing Multiple Sclerosis Treatment.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- المؤلفون: Hauser, Stephen L.1 (AUTHOR) ; Kappos, Ludwig2 (AUTHOR); Bar-Or, Amit3 (AUTHOR); Wiendl, Heinz4 (AUTHOR); Paling, David5 (AUTHOR); Williams, Mitzi6 (AUTHOR); Gold, Ralf7 (AUTHOR); Chan, Andrew8 (AUTHOR); Milo, Ron9 (AUTHOR); Das Gupta, Ayan10 (AUTHOR); Karlsson, Goeril10 (AUTHOR); Sullivan, Roseanne10 (AUTHOR); Graham, Gordon10 (AUTHOR); Merschhemke, Martin10 (AUTHOR); Häring, Dieter A.10 (AUTHOR); Vermersch, Patrick11 (AUTHOR)
- المصدر:
Neurology & Therapy. Oct2023, Vol. 12 Issue 5, p1491-1515. 25p.
No Comments.